A plasma-based test that detects circulating methylated DNA from the SEPT9 gene, which is involved in cytokinesis and cell cycle control.
70% sensitive for colorectal cancer detection at a specificity of 89%.
Detects cancer at all stages.
Demonstrated a sensitivity of 67% and a specificity of 88% in a prospective study of almost 8000 people.